JP2023548145A5 - - Google Patents

Info

Publication number
JP2023548145A5
JP2023548145A5 JP2023526231A JP2023526231A JP2023548145A5 JP 2023548145 A5 JP2023548145 A5 JP 2023548145A5 JP 2023526231 A JP2023526231 A JP 2023526231A JP 2023526231 A JP2023526231 A JP 2023526231A JP 2023548145 A5 JP2023548145 A5 JP 2023548145A5
Authority
JP
Japan
Prior art keywords
serotype
cells
aav
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023526231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548145A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/057380 external-priority patent/WO2022094295A1/en
Publication of JP2023548145A publication Critical patent/JP2023548145A/ja
Publication of JP2023548145A5 publication Critical patent/JP2023548145A5/ja
Pending legal-status Critical Current

Links

JP2023526231A 2020-10-29 2021-10-29 眼の適応症に対するベクター化tnf-アルファアンタゴニスト Pending JP2023548145A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063107415P 2020-10-29 2020-10-29
US63/107,415 2020-10-29
PCT/US2021/057380 WO2022094295A1 (en) 2020-10-29 2021-10-29 Vectorized tnf-alpha antagonists for ocular indications

Publications (2)

Publication Number Publication Date
JP2023548145A JP2023548145A (ja) 2023-11-15
JP2023548145A5 true JP2023548145A5 (enExample) 2024-11-07

Family

ID=78819969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023526231A Pending JP2023548145A (ja) 2020-10-29 2021-10-29 眼の適応症に対するベクター化tnf-アルファアンタゴニスト

Country Status (10)

Country Link
US (1) US20240384292A1 (enExample)
EP (1) EP4237453A1 (enExample)
JP (1) JP2023548145A (enExample)
KR (1) KR20230098176A (enExample)
CN (1) CN116457373A (enExample)
AU (1) AU2021369833A1 (enExample)
CA (1) CA3196964A1 (enExample)
IL (1) IL302282A (enExample)
MX (1) MX2023004843A (enExample)
WO (1) WO2022094295A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024238853A1 (en) * 2023-05-16 2024-11-21 Regenxbio Inc. Adeno-associated viruses for ocular delivery of gene therapy

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT73101A (en) 1993-02-12 1996-06-28 Harvard College Method for regulating transcription of targeted genes and other biological events
ATE544776T1 (de) 1994-12-29 2012-02-15 Massachusetts Inst Technology Chimäre dna-bindeproteine
KR19990022651A (ko) 1995-06-07 1999-03-25 데이비드 엘. 버스테인 생물학적 사건에 대한 라파마이신 기재 조절방법
JP2003524368A (ja) 1997-08-26 2003-08-19 アリアド ジーン セラピューティクス インコーポレイテッド ニ量化ドメイン、三量化ドメインまたは四量化ドメインおよび補足的非相同転写活性化ドメイン、転写抑制ドメイン、dna結合ドメインまたはリガンド結合ドメインを含む融合蛋白
IL134643A0 (en) 1997-08-27 2001-04-30 Ariad Gene Therapeutics Inc Chimeric transcriptional activators and compositions and uses related thereto
WO1999036553A2 (en) 1998-01-15 1999-07-22 Ariad Gene Therapeutics, Inc. Regulation of biological events using multimeric chimeric proteins
JP2002503667A (ja) 1998-02-13 2002-02-05 プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ 新規な二量体化剤、その製造および使用
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
US20090010920A1 (en) 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US8399618B2 (en) 2004-10-21 2013-03-19 Xencor, Inc. Immunoglobulin insertions, deletions, and substitutions
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US20070135620A1 (en) 2004-11-12 2007-06-14 Xencor, Inc. Fc variants with altered binding to FcRn
US7183969B2 (en) 2004-12-22 2007-02-27 Raytheon Company System and technique for calibrating radar arrays
AU2006230419A1 (en) * 2005-03-31 2006-10-05 Targeted Genetics Corporation Methods for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
US7846724B2 (en) 2006-04-11 2010-12-07 Hoffmann-La Roche Inc. Method for selecting CHO cell for production of glycosylated antibodies
WO2009052140A1 (en) * 2007-10-15 2009-04-23 Alcon Research, Ltd. Use of tnf receptor antagonists for treating dry eye
AU2009215987B2 (en) 2008-02-19 2015-01-22 Uniqure Ip B.V. Optimisation of expression of parvoviral rep and cap proteins in insect cells
DK2425000T3 (da) 2009-04-30 2019-05-13 Univ Pennsylvania Sammensætninger rettet mod ledende luftvejsceller omfattende konstrukter af adeno-associeret virus
US8734809B2 (en) 2009-05-28 2014-05-27 University Of Massachusetts AAV's and uses thereof
US10053513B2 (en) 2009-11-30 2018-08-21 Janssen Biotech, Inc. Antibody Fc mutants with ablated effector functions
US8927514B2 (en) 2010-04-30 2015-01-06 City Of Hope Recombinant adeno-associated vectors for targeted treatment
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
US10738326B2 (en) 2010-10-27 2020-08-11 Jichi Medical University Adeno-associated virus vector for gene transfer to nervous system cells
CA2826273C (en) 2011-02-10 2021-11-02 The University Of North Carolina At Chapel Hill Viral vectors with modified transduction profiles and methods of making and using the same
DK3693025T3 (da) 2011-04-22 2022-01-10 Univ California Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
EP3795581A3 (en) 2011-08-24 2021-06-09 The Board of Trustees of the Leland Stanford Junior University New avv capsid proteins for nucleic acid transfer
US9382319B2 (en) 2011-09-26 2016-07-05 Jn Biosciences Llc Hybrid constant regions
EP3470523A1 (en) 2012-05-09 2019-04-17 Oregon Health & Science University Adeno associated virus plasmids and vectors
GB2510803B (en) 2012-11-13 2015-07-22 Cardiff Metropolitan University Trocar assembly
CN103045646B (zh) * 2012-12-27 2015-02-25 中国人民解放军军事医学科学院基础医学研究所 共表达两个独立的抗关节炎分子TNFR-Fc和CTLA4-FasL的重组腺相关病毒载体及其构建方法与应用
CN103131676A (zh) * 2013-01-04 2013-06-05 天津耀宇生物技术有限公司 表达重组人肿瘤坏死因子受体-Fc融合蛋白基因的家蚕重组杆状病毒及其制备方法和应用
TWI682941B (zh) 2013-02-01 2020-01-21 美商再生元醫藥公司 含嵌合恆定區之抗體
EP2970946A4 (en) 2013-03-13 2016-09-07 Philadelphia Children Hospital ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
US9862945B2 (en) 2013-04-20 2018-01-09 Research Institute At Nationwide Children's Hospital Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs
NZ716102A (en) 2013-07-22 2021-12-24 The Children’S Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
EP3564379A1 (en) 2013-09-13 2019-11-06 California Institute of Technology Selective recovery
HUE052676T2 (hu) 2013-10-11 2021-05-28 Massachusetts Eye & Ear Infirmary Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
US10746742B2 (en) 2014-04-25 2020-08-18 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
US10577627B2 (en) 2014-06-09 2020-03-03 Voyager Therapeutics, Inc. Chimeric capsids
US10000551B2 (en) * 2014-09-11 2018-06-19 Protalix Ltd. Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
WO2016049230A1 (en) 2014-09-24 2016-03-31 City Of Hope Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
FR3031112B1 (fr) * 2014-12-24 2018-05-25 Eyevensys Construction d'adn pour le traitement de pathologies oculaires
DK3277725T3 (da) 2015-03-30 2021-01-11 Regeneron Pharma Konstante tungkædeområder med reduceret binding til FC-gammareceptorer
JP6665466B2 (ja) 2015-09-26 2020-03-13 日亜化学工業株式会社 半導体発光素子及びその製造方法
WO2017070491A1 (en) 2015-10-23 2017-04-27 Applied Genetic Technologies Corporation Ophthalmic formulations
IL262207B2 (en) * 2016-04-15 2026-01-01 Univ Pennsylvania Preparations for the treatment of wet age-related macular degeneration
AU2017345470B2 (en) 2016-10-19 2023-08-03 Adverum Biotechnologies, Inc. Modified AAV capsids and uses thereof
KR20200067195A (ko) * 2017-10-18 2020-06-11 리젠엑스바이오 인크. 완전-인간 번역후 변형된 항체 치료제

Similar Documents

Publication Publication Date Title
JP2025039615A (ja) 変異体キャプシドを有するアデノ関連ウイルスビリオンおよびその使用方法
EP1828390B1 (en) Chimeric vectors
JP2021503914A5 (enExample)
JP2023545722A5 (enExample)
CN116568338A (zh) 改进的aav介导的x连锁视网膜劈裂症治疗
JP2023547832A5 (enExample)
JP6719381B2 (ja) 黄斑変性を処置し、予防するための組成物および方法
US20260001917A1 (en) Modified adeno-associated virus capsid proteins and methods thereof
EP2986310A1 (en) Compositions and methods for treating and preventing macular degeneration
CA3186830A1 (en) Composition and method for treating eye diseases
KR20240004316A (ko) 혈관신생과 관련된 안구 질환의 치료를 위한 조성물 및 방법
JP2024505948A (ja) タンパク質m類似体及び融合タンパク質、並びに抗体機能を阻害するためのそれらの使用
CN114126667A (zh) 使用糖苷水解酶的基因疗法载体向视网膜细胞的改进递送
JP2023547832A (ja) 眼の適応症に対するベクター化抗TNF-α抗体
CN118853712A (zh) 编码抗vegf蛋白的核酸、多核苷酸表达盒及重组腺相关病毒
CA3206107A1 (en) Vector constructs for delivery of nucleic acids encoding therapeutic anti-tnf antibodies and methods of using the same
CN113347962B (zh) 通过合理设计增强的新型aav病毒在视网膜中的高效转导和侧向扩散
TW202417633A (zh) 用於眼適應症之載體化抗TNF-α抑制劑
US20240384292A1 (en) Vectorized tnf-alpha antagonists for ocular indications
HK40128489A (en) Compositions and methods for treating and preventing macular degeneration
JP2025536506A5 (enExample)
CN117587028A (zh) 编码抗vegf的抗体或抗原结合片段的多核苷酸表达盒及质粒
CN119264217A (zh) 具有变异衣壳蛋白的腺相关病毒及其应用
CN117070541A (zh) 编码抗vegf蛋白的多核苷酸表达盒、质粒及重组腺相关病毒
CN120641137A (zh) 重组腺相关病毒载体